| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5084
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5078
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2072 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50 |
| filingDate |
2000-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b314f6111b28d998fcff9c317321925
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dcd9798d24bb7bb0a95340de9a2a989d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_59caafd6dc3fb1038a3d99b956dcbc09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff50cc32e8121b609ef5067900fbff85 |
| publicationDate |
2002-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TR-200200683-T2 |
| titleOfInvention |
Oral controlled release formulations. |
| abstract |
For example, the pharmaceutical composition capable of releasing the therapeutically effective dose of an active agent such as rivastigmine in a time-controlled method. |
| priorityDate |
1999-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |